MCF Advisors’s Biogen BIIB Stock Holding History

MCF Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.4K	Buy	346 +22	+7%	+$4.05K	﹤0.01%	570
2025 Q4	$57K	Hold	324	–	–	﹤0.01%	488
2025 Q3	$45.4K	Hold	324	–	–	﹤0.01%	448
2025 Q2	$40.7K	Hold	324	–	–	﹤0.01%	435
2025 Q1	$44.3K	Hold	324	–	–	﹤0.01%	410
2024 Q4	$49.5K	Sell	324 -6	-2%	-$1.01K	﹤0.01%	403
2024 Q3	$64K	Hold	330	–	–	﹤0.01%	355
2024 Q2	$76.5K	Buy	330 +6	+2%	+$1.3K	0.01%	330
2024 Q1	$69.9K	Sell	324 -15	-4%	-$3.51K	0.01%	332
2023 Q4	$87.7K	Sell	339 -1	-0.3%	-$246	0.01%	311
2023 Q3	$87.4K	Sell	340 -37	-10%	-$9.9K	0.01%	306
2023 Q2	$107K	Hold	377	–	–	0.01%	277
2023 Q1	$105K	Buy	377 +120	+47%	+$33.2K	0.01%	277
2022 Q4	$71.2K	Buy	257 +4	+2%	+$1.13K	0.01%	311
2022 Q3	$68K	Hold	253	–	–	0.01%	304
2022 Q2	$52K	Sell	253 -6	-2%	-$1.23K	0.01%	312
2022 Q1	$55K	Buy	+259	New	+$56.3K	0.01%	314
2021 Q4	–	Sell	-210	Closed	-$59K	–	113
2021 Q3	$59K	Buy	210 +6	+3%	+$1.97K	0.01%	285
2021 Q2	$71K	Buy	204 +19	+10%	+$5.76K	0.01%	259
2021 Q1	$52K	Hold	185	–	–	0.01%	266
2020 Q4	$45K	Hold	185	–	–	0.01%	251
2020 Q3	$52K	Hold	185	–	–	0.01%	235
2020 Q2	$49K	Hold	185	–	–	0.01%	231
2020 Q1	$59K	Hold	185	–	–	0.01%	217
2019 Q4	$55K	Hold	185	–	–	0.01%	240
2019 Q3	$43K	Hold	185	–	–	0.01%	252
2019 Q2	$43K	Hold	185	–	–	0.01%	240
2019 Q1	$44K	Hold	185	–	–	0.01%	230
2018 Q4	$56K	Sell	185 -20	-10%	-$6.38K	0.01%	205
2018 Q3	$72K	Hold	205	–	–	0.01%	191
2018 Q2	$59K	Sell	205 -3	-1%	-$843	0.01%	200
2018 Q1	$57K	Hold	208	–	–	0.01%	198
2017 Q4	$66K	Hold	208	–	–	0.01%	199
2017 Q3	$65K	Buy	208 +20	+11%	+$5.92K	0.01%	200
2017 Q2	$51K	Buy	188 +3	+2%	+$793	0.01%	222
2017 Q1	$51K	Hold	185	–	–	0.01%	228
2016 Q4	$52K	Hold	185	–	–	0.01%	203
2016 Q3	$58K	Hold	185	–	–	0.01%	191
2016 Q2	$45K	Hold	185	–	–	0.01%	231
2016 Q1	$48K	Hold	185	–	–	0.01%	192
2015 Q4	$57K	Sell	185 -147	-44%	-$42.2K	0.02%	165
2015 Q3	$97K	Hold	332	–	–	0.02%	139
2015 Q2	$134K	Hold	332	–	–	0.03%	119
2015 Q1	$140K	Hold	332	–	–	0.03%	117
2014 Q4	$113K	Sell	332 -55	-14%	-$17.8K	0.03%	128
2014 Q3	$118K	Hold	387	–	–	0.03%	129
2014 Q2	$118K	Sell	387 -46	-11%	-$13.8K	0.04%	126
2014 Q1	$132K	Hold	433	–	–	0.04%	118
2013 Q4	$132K	Buy	433 +33	+8%	+$8.54K	0.05%	110
2013 Q3	$122K	Hold	400	–	–	0.07%	115
2013 Q2	$122K	Buy	+400	New	+$85.5K	0.07%	106

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MCF Advisors's BIIB Position: Q1 2026 in Review

MCF Advisors increased its Biogen (BIIB) stake by 6.8% in Q1 2026, buying an estimated $4.05K and bringing the position to 346 shares worth $63.4K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

MCF Advisors first reported a position in BIIB in Q2 2013 and has held it in 51 quarters since. The position peaked at $140K in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

MCF Advisors held 346 shares of Biogen worth $63.4K as of Q1 2026.
MCF Advisors bought 22 Biogen shares in Q1 2026, an estimated $4.05K.
Biogen made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #570 holding.
MCF Advisors first reported a position in Biogen in Q2 2013 and has held it in 51 quarters since.
MCF Advisors's Biogen position peaked at $140K in Q1 2015.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.